{"license":"https://creativecommons.org/licenses/by/4.0/","dataset":"atlas","mode":"comparison","updatedThrough":"2026-08-15","guardrail":"A bilateral atlas route preserves a sequence of declared edges for navigation and audit. A direct edge, common neighbor, or multi-hop path does not make the endpoints equivalent, establish ownership or control, assign liability, define an antitrust market, make unlike measures comparable, or show causation.","filters":{"layer":"all","layerMatched":true,"left":"source:ftc-pbm-interim-2024","leftMatched":true,"right":"report:rep-public-data-gaps","rightMatched":true,"view":"paths"},"summary":{"nodeCount":5478,"edgeCount":19193,"sourceCount":1,"profileCount":5433,"nodeKindCount":13,"layerCount":4,"directEdgeCount":1,"disconnected":false,"eligibleEdgeCount":19193,"ledgerEdgeCount":3,"leftNeighborCount":4,"pathLimitReached":false,"rightNeighborCount":5,"sharedNeighborCount":1,"shortestHopCount":1,"shortestPathCount":1},"endpoints":{"left":{"id":"source:ftc-pbm-interim-2024","kind":"source","label":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","shortLabel":"Federal Trade Commission","description":"FTC interim staff report and press release on PBM concentration and vertical integration.","href":"/sources/ftc-pbm-interim-2024","metricLabel":"Access date","metricValue":"2026-05-16","detail":"Federal Trade Commission","status":"agency report","year":2026,"color":"#64748b","searchText":"ftc-pbm-interim-2024 pharmacy benefit managers: the powerful middlemen inflating drug costs and squeezing main street pharmacies federal trade commission ftc interim staff report and press release on pbm concentration and vertical integration. federal trade commission, ftc releases interim staff report on prescription drug middlemen, july 9 2024. agency_report","connectionCount":4},"right":{"id":"report:rep-public-data-gaps","kind":"report","label":"Where Public Market-Share Data Runs Out","shortLabel":"Where Public Market-Sha...","description":"An open report explaining why the observatory sometimes withholds HHI even when public facts indicate concentration.","href":"/reports/public-data-gaps","metricLabel":"Evidence sources","metricValue":"2","detail":"2 linked markets","status":"published","year":2026,"color":"#6366f1","searchText":"where public market-share data runs out why incomplete profiles are part of the product an open report explaining why the observatory sometimes withholds hhi even when public facts indicate concentration. a transparency note on incomplete data and why the observatory never fills gaps with invented shares. bts public airline market-share table and ftc pbm interim staff report materials.","connectionCount":5}},"shortestPaths":[{"id":"path:report-source:rep-public-data-gaps:ftc-pbm-interim-2024","edges":[{"id":"report-source:rep-public-data-gaps:ftc-pbm-interim-2024","type":"report_source","layer":"research","from":"report:rep-public-data-gaps","to":"source:ftc-pbm-interim-2024","label":"Declared publication source","detail":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies appears in the report's encoded source basis.","evidenceLabel":"Federal Trade Commission","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","guardrail":"A source edge records the public evidence basis declared by the publication and does not erase the source's limitations."}],"hopCount":1,"nodes":[{"id":"source:ftc-pbm-interim-2024","kind":"source","label":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","shortLabel":"Federal Trade Commission","description":"FTC interim staff report and press release on PBM concentration and vertical integration.","href":"/sources/ftc-pbm-interim-2024","metricLabel":"Access date","metricValue":"2026-05-16","detail":"Federal Trade Commission","status":"agency report","year":2026,"color":"#64748b","searchText":"ftc-pbm-interim-2024 pharmacy benefit managers: the powerful middlemen inflating drug costs and squeezing main street pharmacies federal trade commission ftc interim staff report and press release on pbm concentration and vertical integration. federal trade commission, ftc releases interim staff report on prescription drug middlemen, july 9 2024. agency_report","connectionCount":4},{"id":"report:rep-public-data-gaps","kind":"report","label":"Where Public Market-Share Data Runs Out","shortLabel":"Where Public Market-Sha...","description":"An open report explaining why the observatory sometimes withholds HHI even when public facts indicate concentration.","href":"/reports/public-data-gaps","metricLabel":"Evidence sources","metricValue":"2","detail":"2 linked markets","status":"published","year":2026,"color":"#6366f1","searchText":"where public market-share data runs out why incomplete profiles are part of the product an open report explaining why the observatory sometimes withholds hhi even when public facts indicate concentration. a transparency note on incomplete data and why the observatory never fills gaps with invented shares. bts public airline market-share table and ftc pbm interim staff report materials.","connectionCount":5}]}],"sharedNeighbors":[{"leftEdges":[{"id":"market-source:mkt-pbm:ftc-pbm-interim-2024","type":"market_source","layer":"measurement","from":"market:mkt-pbm","to":"source:ftc-pbm-interim-2024","label":"Market evidence custody","detail":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies supports the profile's definition, observation.","evidenceLabel":"Federal Trade Commission","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","guardrail":"A source link identifies evidence used by a market profile and does not endorse every claim in the underlying record."}],"node":{"id":"market:mkt-pbm","kind":"market","label":"U.S. pharmacy benefit management","shortLabel":"PBMs","description":"Pharmacy benefit management services profile based on FTC public findings. The FTC reports top-three and top-six aggregate shares but not enough individual PBM market shares in the public press-release record to compute HHI.","href":"/markets/us-pharmacy-benefit-management","metricLabel":"HHI status","metricValue":"Withheld","detail":"United States / 2023","status":"incomplete","year":2023,"color":"#14b8a6","searchText":"u.s. pharmacy benefit management pbms health care united states pharmacy benefit management services profile based on ftc public findings. the ftc reports top-three and top-six aggregate shares but not enough individual pbm market shares in the public press-release record to compute hhi.","connectionCount":10},"rightEdges":[{"id":"report-market:rep-public-data-gaps:mkt-pbm","type":"report_market","layer":"research","from":"report:rep-public-data-gaps","to":"market:mkt-pbm","label":"Covered market profile","detail":"Where Public Market-Share Data Runs Out explicitly lists U.S. pharmacy benefit management in its related-market scope.","evidenceLabel":"Report scope contract","sourceId":null,"sourceUrl":null,"confidenceLevel":"bounded","guardrail":"A publication link identifies an explicitly covered market profile and does not make separately defined markets interchangeable."}]}],"nodes":[{"id":"market:mkt-pbm","kind":"market","label":"U.S. pharmacy benefit management","shortLabel":"PBMs","description":"Pharmacy benefit management services profile based on FTC public findings. The FTC reports top-three and top-six aggregate shares but not enough individual PBM market shares in the public press-release record to compute HHI.","href":"/markets/us-pharmacy-benefit-management","metricLabel":"HHI status","metricValue":"Withheld","detail":"United States / 2023","status":"incomplete","year":2023,"color":"#14b8a6","searchText":"u.s. pharmacy benefit management pbms health care united states pharmacy benefit management services profile based on ftc public findings. the ftc reports top-three and top-six aggregate shares but not enough individual pbm market shares in the public press-release record to compute hhi.","connectionCount":10},{"id":"report:rep-public-data-gaps","kind":"report","label":"Where Public Market-Share Data Runs Out","shortLabel":"Where Public Market-Sha...","description":"An open report explaining why the observatory sometimes withholds HHI even when public facts indicate concentration.","href":"/reports/public-data-gaps","metricLabel":"Evidence sources","metricValue":"2","detail":"2 linked markets","status":"published","year":2026,"color":"#6366f1","searchText":"where public market-share data runs out why incomplete profiles are part of the product an open report explaining why the observatory sometimes withholds hhi even when public facts indicate concentration. a transparency note on incomplete data and why the observatory never fills gaps with invented shares. bts public airline market-share table and ftc pbm interim staff report materials.","connectionCount":5},{"id":"source:ftc-pbm-interim-2024","kind":"source","label":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","shortLabel":"Federal Trade Commission","description":"FTC interim staff report and press release on PBM concentration and vertical integration.","href":"/sources/ftc-pbm-interim-2024","metricLabel":"Access date","metricValue":"2026-05-16","detail":"Federal Trade Commission","status":"agency report","year":2026,"color":"#64748b","searchText":"ftc-pbm-interim-2024 pharmacy benefit managers: the powerful middlemen inflating drug costs and squeezing main street pharmacies federal trade commission ftc interim staff report and press release on pbm concentration and vertical integration. federal trade commission, ftc releases interim staff report on prescription drug middlemen, july 9 2024. agency_report","connectionCount":4}],"rows":[{"id":"market-source:mkt-pbm:ftc-pbm-interim-2024","layer":"measurement","relationshipType":"market_source","relationshipLabel":"Market evidence custody","fromId":"market:mkt-pbm","fromKind":"market","fromLabel":"U.S. pharmacy benefit management","fromHref":"/markets/us-pharmacy-benefit-management","toId":"source:ftc-pbm-interim-2024","toKind":"source","toLabel":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","toHref":"/sources/ftc-pbm-interim-2024","evidenceLabel":"Federal Trade Commission","evidenceDetail":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies supports the profile's definition, observation.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A source link identifies evidence used by a market profile and does not endorse every claim in the underlying record."},{"id":"report-market:rep-public-data-gaps:mkt-pbm","layer":"research","relationshipType":"report_market","relationshipLabel":"Covered market profile","fromId":"report:rep-public-data-gaps","fromKind":"report","fromLabel":"Where Public Market-Share Data Runs Out","fromHref":"/reports/public-data-gaps","toId":"market:mkt-pbm","toKind":"market","toLabel":"U.S. pharmacy benefit management","toHref":"/markets/us-pharmacy-benefit-management","evidenceLabel":"Report scope contract","evidenceDetail":"Where Public Market-Share Data Runs Out explicitly lists U.S. pharmacy benefit management in its related-market scope.","sourceId":null,"sourceUrl":null,"confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A publication link identifies an explicitly covered market profile and does not make separately defined markets interchangeable."},{"id":"report-source:rep-public-data-gaps:ftc-pbm-interim-2024","layer":"research","relationshipType":"report_source","relationshipLabel":"Declared publication source","fromId":"report:rep-public-data-gaps","fromKind":"report","fromLabel":"Where Public Market-Share Data Runs Out","fromHref":"/reports/public-data-gaps","toId":"source:ftc-pbm-interim-2024","toKind":"source","toLabel":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","toHref":"/sources/ftc-pbm-interim-2024","evidenceLabel":"Federal Trade Commission","evidenceDetail":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies appears in the report's encoded source basis.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A source edge records the public evidence basis declared by the publication and does not erase the source's limitations."}]}